Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × AMG 757 × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2 Genitourinary 1 Endocrine 1

Conditions

Neuroendocrine Prostate Cancer 1

Interventions

Everolimus 20 Octreotide 10 pasireotide 8 lanreotide 8 Sunitinib 8 Magnetic Resonance Spectroscopy 7 Bevacizumab 7 pembrolizumab 6 lenvatinib 6 cabozantinib 6 Cisplatin 6 pazopanib 5 Temozolomide 5 Sorafenib 5 Etoposide 5 Doxorubicin 5 vandetanib 4 lutetium Lu 177 dotatate 4 gallium Ga 68 dotatate 4 Paclitaxel 4 Nivolumab 4 Carboplatin 4 Capecitabine 4 ribociclib 3 durvalumab 3 cixutumumab 3 arginyllysine 3 Specimen Handling 3 Mitotane 3 Mifepristone 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04702737 2025-09-12

DeLLpro-300

Amgen

Phase 1 Completed

41 enrolled 19 charts

EndocrineGenitourinary

Neuroendocrine Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡